Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop.

MLA

UCL - SSS/DDUV - Institut de Duve, et al. “Immunomodulatory Antibodies for the Treatment of Lymphoma: Report on the CALYM Workshop.” OncoImmunology, Vol. 5, No.7, p. E1186323 (2016), 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1130463381&authtype=sso&custid=ns315887.

APA

UCL - SSS/DDUV - Institut de Duve, Houot, R., Gaulard, P., Schreiber, R., Mellman, I., Lambotte, O., Coulie, P., Fest, T., Korman, A., Levy, R., Shipp, M., Tarte, K., Kohrt, H., Marabelle, A., Ansell, S., Watier, H., van Elsas, A., Balakumaran, A., Arce Vargas, F., … Olive, D. (2016). Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop. OncoImmunology, Vol. 5, No.7, p. E1186323 (2016).

Chicago

UCL - SSS/DDUV - Institut de Duve, Roch Houot, Philippe Gaulard, Robert Schreiber, Ira Mellman, Olivier Lambotte, Pierre Coulie, et al. 2016. “Immunomodulatory Antibodies for the Treatment of Lymphoma: Report on the CALYM Workshop.” OncoImmunology, Vol. 5, No.7, p. E1186323 (2016). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1130463381&authtype=sso&custid=ns315887.